News and Updates

Dr. Robert Langer co-founded Moderna, who gained emergency use approval for its COVID vaccine. Watch the video to find out how Breakthrough T1D is helping to advance his research.

A Breakthrough T1D-funded clinical trial will test if a JAK inhibitor will preserve beta cell function in children and young adults with recently diagnosed T1D.

“We’ve been too focused on [insulin],” Jeremy Pettus, M.D., an endocrinologist at UC San Diego, says. Watch the video to find out why.

JDRF-funded researchers have discovered a protein on immune cells that, when it is disabled, could halt immune cell memory.

SFC Fluidics, a Breakthrough T1D partner, received a breakthrough device designation for its interoperable insulin delivery pod. How is it different? Find out here.

In 1974, two teams showed that diabetes is associated with antibodies against beta cells, which helped establish T1D as an autoimmune disease.

Breakthrough T1D is launching T1Detect, a community-based education and awareness program to expand screening to the general population.

Breakthrough T1D today launched a Center of Excellence at the University of Michigan, to expand the University’s already stellar Elizabeth Weiser Caswell Diabetes Institute to tackle some of the most critical challenges in diabetes research. The goal: To yield safer day-to-day management and improved health for people with T1D by developing a comprehensive understanding of T1D metabolism.

Hear Dr. Elad Sintov talk about his research into beta cell replacement technology with our new video.

With Breakthrough T1D support, ARMI is translating the Millman procedure into an automated process to generate an unlimited amount of stem cell-derived beta cells.